Figures
Abstract
Background
The placenta is a transient organ critical for fetal development. Disruptions of normal placental functions can impact health throughout an individual’s entire life. Although being recognized by the NIH Human Placenta Project as an important organ, the placenta remains understudied, partly because of a lack of non-invasive tools for longitudinally evaluation for key aspects of placental functionalities.
Objective
Our goal is to create a non-invasive preclinical imaging pipeline that can longitudinally probe murine placental health in vivo. We use advanced imaging processing schemes to establish functional biomarkers for non-invasive longitudinal evaluation of placental development.
Methodology
We implement dynamic contrast enhancement magnetic resonance imaging (DCE-MRI) and analysis pipeline to quantify uterine contraction and placental perfusion dynamics. We use optic flow and time-frequency analysis to quantify and characterize contraction-related placental motion. Our novel imaging and analysis pipeline uses subcutaneous administration of gadolinium for steepest slope-based perfusion evaluation, enabling non-invasive longitudinal monitoring.
Results
We demonstrate that the placenta exhibits spatially asymmetric contractile motion that develops from E14.5 to E17.5. Additionally, we see that placental perfusion, perfusion delivery rate, and substrate delivery all increase from E14.5 to E17.5, with the High Perfusion Chamber (HPC) leading the placental changes that occur from E14.5 to E17.5
Discussion
We advance the placental perfusion chamber paradigm with a novel, physiologically based threshold model for chamber localization and demonstrate spatially varying placental chambers using multiple functional metrics that assess mouse placental development and remodeling throughout gestation.
Citation: Cortes DRE, Stapleton MC, Schwab KE, West D, Coulson NW, O’Donnell MG, et al. (2024) Modeling normal mouse uterine contraction and placental perfusion with non-invasive longitudinal dynamic contrast enhancement MRI. PLoS ONE 19(7): e0303957. https://doi.org/10.1371/journal.pone.0303957
Editor: Barbara Wilson Engelhardt, Monroe Carell Junior Children’s Hospital at Vanderbilt, UNITED STATES
Received: August 29, 2023; Accepted: May 5, 2024; Published: July 1, 2024
Copyright: © 2024 Cortes et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All raw data and statistics files are available from the github database (https://github.com/cortes-etal/normal-mouse-uterine-contraction-and-placental-perfusion).
Funding: YLW National Institute of Health EB023507, NS121706-01 https://www.nih.gov/ YLW American Heart Association 18CDA34140024 heart.org YLW Department of Defense W81XWH1810070, W81XWH-22-1-0221 https://www.defense.gov/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Abbreviations: DOHaD, Developmental Origins of Health and Disease; MGD, Mouse Genome Database; KOMP, Knockout Mouse Genome Database; IMPC, International Mouse Phenotyping Consortium; DCE-MRI, Dynamic Contrast Enhancement Magnetic Resonance Imaging; Gd, Gadolinium; IV, Intravenous; AIF, Arterial Input Function; PDFs, Probability Density Functions; AUC, Area Under Curve; ABV, Apparent Blood Volume; R1, Longitudinal Relaxation Rate; T1, Longitudinal Relaxation Time; ROI, Region of Interest; AGU, Apparent Gadolinium Uptake; MRI, Magnetic Resonance Imaging; BD-ASL, Bi-directional Arterial Spin Labeling; subQ, Subcutaneous; WT, Wildtype; FOV, Field of View; TE, Echo Time; TR, Repetition Time; FA, Flip Angle; NR, Number of Repetitions; MIP, Maximum Intensity Projection; EM, Expectation–Maximization; FWHM, Full Width at Half Maximum; HS, Horn Shuck; PSD, Power Spectral Density; ANOVA, Analysis of Variance
Introduction
As identified by the NIH Human Placenta Project, the placenta is an important organ that can have a lasting impact on health beyond the developmental period across the lifespan. The placenta has a prominent role in fetal growth and development [1,2] by regulation of nutrient and gas exchange between the developing fetus and the mother. Therefore, placental health directly impacts fetal and pregnancy outcomes [3–5]. Furthermore, the placenta not only affects the pregnant person and the developing fetus, but also impacts an array of adult-onset diseases later in life, recognized as the “developmental origins of health and disease” (DOHaD) [6–8]. However, its functions are poorly understood, partly because of a lack of quantitative and sensitive imaging-based criteria that can continually assess physiological remodeling of placenta throughout gestation.
Placental studies can be difficult to carry out or interpret in human subjects due to ethical concerns of randomization for pregnancy outcomes, wide ranges of genetic backgrounds, and maternal co-morbidity influencing pregnancy outcomes in the singleton pregnancy. Animal models, therefore, are indispensable in modeling human placental conditions for mechanistic understanding and therapeutic development. Murine and human placentas follow similar developmental programs [9–11], but each mouse pregnancy can carry 6–12 fetuses with different genotypes in the same maternal environment, allowing contributions of maternal co-morbidity vs intrinsic fetal factors of the fetoplacental units to be differentiated. With the advancement of gene editing with CRISPR-Cas9 system [12–14], availability of the Mouse Genome Database (MGD) [15,16], systematic production of knockout mice with NIH Knockout Mouse Production and Phenotyping Project (KOMP) [17] and International Mouse Phenotyping Consortium (IMPC) [18,19], an unprecedented number of genetically engineered mouse models are now available for interrogating mechanisms underlying human diseases. Many of these mice have placental abnormalities. A recent screening of more than 100 embryonic lethal mouse mutants found that the placenta is morphologically abnormal in approximately two-thirds of embryonic lethal mutant mouse lines [1]. However, most of the understanding of placental biology came from studying ex vivo placental tissues. It lacks a robust in vivo tool for characterizing placental functions across gestational stages. The goal of this study is to establish non-invasive MRI imaging biomarkers for uterine motions and placental perfusion longitudinally in normal pregnancy of wild type (WT) mice.
Phasic uterine contractions are the essential part of parturition for birthing and minimizing postpartum hemorrhage [20–23]. An in-vivo pipeline and contraction biomarkers are necessary for understanding placental and uterine contractions as it relates to overall gestation. Abnormal uterine contractions can lead to labor complications [24–27] resulting in high risks of maternal mortality and morbidity. It can also cause preterm birth [28,29], which is the leading cause of infant mortality and morbidity [30,31]. In addition to contractions for labors and uterine atony, the occurrences of Braxton Hicks contractions increase [32–34] as the pregnancy nears birth. However, phasic contractions in mice were only observed in ex vivo vagina and cervix tissues, but not in live mouse pregnancy. It is lacking an in vivo tool for evaluating mouse uterine contractions.
To support fetal growth and development, the placenta is undergoing constant remodeling and growth. In particular, the labyrinth zone in mouse placenta is the primary location for maternal-fetal nutrient exchange, characterized by an extensive surface area of villi, the finger-like protrusions that contain blood-sinusoids for maternal blood flow. These blood-sinusoids encounter fetal blood vessels and counter-concurrent flow of the two blood supplies facilitates exchange [1,2,35]. The labyrinth zone begins formation around embryonic day 9.5 [E9.5] and is functionally developed by placental maturity at E12.5. However, the labyrinth zone continues to grow all the way through E18.5 [1–3,36,37]. Additionally, the junctional zone (Jz) serves as the endocrine factory of the placenta. It produces various peptides including growth factors, hormones, and chemokines that facilitate pregnancy progression [36]. Most interestingly, it acts on both fetal and maternal physiology and regulates dynamic crosstalk between the decidua and labyrinth zone. The decidua is the maternal tissue that undergoes drastic remodeling after implantation. Specifically, there is large-scale remodeling of maternal vascularization of the decidua. Small blood vessel systems develop into large, dilated ones and there are local changes in vascular elasticity and overall nutrient transport [37]. As vasculature remodeling is a critical function of placental development, non-invasive imaging tools to study perfusion, blood-flow, and hemodynamics are critical to understanding placental function as it relates to fetal development and pregnancy outcomes in vivo.
The two-pronged objective of this study is to establish in vivo non-invasive imaging-based biomarkers for quantitative evaluations of mouse uterine contractions in conjunction with advancing the placental perfusion chamber model with a physiologically based threshold for automatic localization of the high and low perfusion chambers. We apply computer vision and digital signal processing techniques to study uterine contractions in vivo. Briefly, we used optic flow to quantify the placental motion associated with late-term, spontaneous uterine contractions. Further, we characterized the frequency content of the contractile-motion signal via advanced time-frequency analysis: the spectrogram and the periodogram. Thus, we have created the first in-vivo research tool for phenotypic investigation of late-term and spontaneous pregnancy contractions. Pre-clinical studies of pharmaceuticals designed to modulate late-term and spontaneous contractions can utilize these methods to longitudinally study drug effects in-vivo. Further, basic research can benefit as equally as this work expands the toolbox for longitudinal experimental design. Combining advanced analytical tools with placental MRI optimized for intra-animal temporal studies results in a non-invasive, in-vivo pipeline for high-throughput phenotypic studies for key stages of fetal and placental development.
Dynamic contrast enhancement MRI (DCE-MRI) with steepest slope models have been used to quantify placental perfusion in mice. Unique to our method is that it utilizes a subcutaneous administration of gadolinium-based contrast agent (Gd) for the longitudinal visualization of placental development. Our method elicits the ability to conduct longitudinal experimental studies via the ease of subcutaneous administration. This imaging protocol is coupled with advanced image and signal processing biomarkers to understand, monitor, and model uterine-related contractions, placental perfusion, apparent contrast uptake, and fetal motion throughout pregnancy. We advanced the placental perfusion chamber model of the placenta using a novel physiological threshold for the automatic localization. This threshold is derived from stereological analysis performed by Coan et. al. on histological specimens of mouse placentas [37]. They utilized grid-based counting methods to evaluate the volume contributions of different placental chambers throughout placental development from E12.5 to E18.5. Our automatic perfusion chamber localization is enabled by applying these volumetric contributions as quantitative thresholds to the perfusion probability density functions of the mouse placenta. We successfully reproduced the paradigm that the labyrinth zone and the decidua can be localized through spatial patterning in peak perfusion and expanded this paradigm to include the steepest slope modeling of the placental perfusion and apparent gadolinium uptake. Differences in the steepest slope represent changes in the instantaneous perfusion rate through the placenta; while the apparent gadolinium uptake measures the cumulative gadolinium in the tissue over the course of the imaging study. Changes in placental perfusion and placental vascular resistance were observed during the Braxton Hicks contractions [32–34]. We further examined if uterine motions affected quantitative perfusion measured by DCE.
Results
Characterization of spontaneous uterine contractions
DCE with T1-weighted condition was used to highlight the uterine wall and placenta. Time-series of the DCE images revealed extensive regular and phasic uterine motions for some placenta-fetal units. This phasic motion was still present even after removing maternal respiration motions with temporal median filtering and eliminating random large translations between frames with morphological closing. This motion was localized to the placenta-fetal units and appeared to be more pronounced on E17.5. Visual examination of each placenta revealed that the phasic motion was present in ~11.1% of the placenta on E14.5, versus ~82.1% on E17.5. Optical flow quantification allows us to visualize this motion in the form of velocity vectors overlaid on the DCE-MRI time series. Fig 1A and 1B shows continuous time frames of a single slice of DCE-MR images with the optical flow velocity vectors overlaid on E14.5 (Fig 1A) and E17.5 (Fig 1B). Larger magnitude of velocity vectors was seen in the E17.5 time series compared to those of the E14.5 ones. The averaged magnitude of the velocity vectors was significantly larger on E17.5 than on E14.5, regardless of if the motions were measured from the high perfusion chamber, the lower perfusion chambers, or across the entire placentas. (Fig 1C). This indicates that the uterine motions were more profound with larger amplitudes on E17.5 than on E14.5.
Flow vectors are overlaid on the original MR images for a single slice of the same animal at A) E14.5 and B) E17.5 over continuous frames. Average magnitude of velocity vectors for the whole placenta and its different perfusion chambers are compared via violin plot in C. (** = p < 0.01, *** = p < 0.001, **** = p < 0.0001).
Time-frequency and spectrum analysis of the phasic motion traces for each placenta (Fig 2) and its chambers revealed differential frequency components on E14.5 (Fig 2A and 2B) compared to those on E17.5 (Fig 2C and 2D). Periodograms (Fig 2A and 2C) were used to identify the dominant frequencies in the time series, whereas the spectrograms (Fig 8B and 8D) were used to express the power of the dominant frequencies of these phasic uterine motions over the imaging session. On E14.5 (Fig 2A), the periodograms expressed the highest power only as the frequency approaching zero which is normal for most time series with some autocorrelation. The spectrogram of phasic motions on E14.5 (Fig 2B) demonstrated that there were no instantaneous changes in frequency components over the time course. Further, when this data is stratified by the different perfusion chambers for the high perfusion chamber (Fig 2A and 2B, left), lower perfusion chamber (Fig 2A and 2B, middle) or the whole placenta (Fig 2A and 2B, right), no differences appeared in the periodogram estimation or the spectrograms among different compartments. On the other hand, looking at the phasic motion signals from E17.5 (Fig 2C and 2D), specifically the periodograms (Fig 2C) and spectrograms (Fig 2D) for the high perfusion chamber (Fig 2C and 2D, left) exhibited an increase in frequency components from around 8–12 mHz, 15 mHz, and 25 mHz. However, the frequency characterization for the low perfusion chamber (Fig 2C and 2D, middle) matched with that of all chambers on E14.5 (Fig 2A and 2B). The periodograms (Fig 2C, right) and spectrograms (Fig 2D, right) of the whole placenta on E17.5 appeared as an average of the frequency elements contributing from the high (Fig 2C and 2D, left) and low perfusion (Fig 2C and 2D, middle) chambers, representing asymmetric motion of the mouse placenta on E17.5. All these frequency elements from the phasic motions are much slower than the maternal respiration (~1.3 Hz) or heart rates (~6.7 Hz).
A) PSD estimation and B) spectrogram at E14.5, C) PSD estimation and D] spectrogram at E17.5. Notice the lack of power present in the higher frequencies at E14.5 to E17.5 in the high perfusion chamber. This change in frequency power was not seen in the low perfusion chamber and seen in the whole perfusion chamber because of whole placental averaging. Relative Spectral Density sub band maps for the same litter at E-F) E14.5 and G-H) E17.5. E and G are the same images as F and H except with placentas segmented and overlaid on top of their original DCE-MR frames. E and G are provided to provide context of the relative power seen throughout the rest of the imaged tissue. Note much of the spectral density is localized to the same region and orientation as the high perfusion chamber.
We further investigated the spatial localization of the most dominant sub-bands from the power spectrum analysis. The relative power spectrum of the 8–12 mHz sub band (Fig 2E–2H) was computed as a ratio to the total power in the entire spectrum range for each voxel in the DCE-time series and viewed as relative power maps for E14.5 (Fig 2E) and E17.5 (Fig 2G). These relative power maps demonstrated that the voxels showing the 8–12 mHz phasic motions were localized to the placenta-fetal units, but not the maternal abdominal organs. No relative frequency components within the 8–12 mHz sub bands were present in the kidney or across the abdomen but were specifically localized to the placenta and uterine walls. Moreover, the voxels with an increase in spectral density across the 8–12 mHz sub bands were localized to the high perfusion zones in the placenta. We confirmed this further by applying the placental segmentations to the relative motion power maps, and then overlaid them over the original MR anatomical images (Fig 2F and 2H). The voxels with the highest relative power of the phasic motions coincide with the voxels with the high perfusion chambers. The relative power maps of the phasic motions (Fig 2F and 2H) displayed the same spatial pattern as the high perfusion chambers seen in the dynamic perfusion characterization of the different placental chambers (Figs 4 and 5).
Optimization of subcutaneous gadolinium (Gd) contrast agent administration for steepest-slope perfusion modeling
We have optimized the subcutaneous Gd administration and imaging acquisition protocol to enable quantitative placental perfusion mapping with the steepest slope model [38–43] repetitive intravenous (IV) administration of contrast agent in mice for longitudinal DCE investigation is difficult. Administration via common mouse iv administration routes like femoral, jugular, or retro orbital veins is terminal and cannot be used for longitudinal monitoring. Although tail-vein injection [38,39] can be performed multiple times, quantitative DCE requires administration of Gd contrast agent via an IV catheter inside the magnet during DCE acquisition, which is difficult for multiple administration longitudinally. Therefore, most mouse placental DCE studies with the steepest slope model were performed with single imaging time points. The developmental trajectory across gestation was constructed using different animals, instead of longitudinal monitoring of the same mice. On the contrary, our subcutaneous method can be performed easily with high reproducibility behooving longitudinal studies of disease and fetal development within the same subject. We have optimized the Gd administration timing and concentration to enable the steepest slope model with optimal arterial input function (AIF). Fig 3A illustrates example DCE time-series images of a mid-slice of a pregnant dam on E14.5 and E17.5 following a single bolus Gd administration via a subcutaneous catheter in the MRI scanner. As Gd contrast agent is taken up by the placenta, the T1-weighted signal intensity increases. The multi-planar imaging volume covers the entire abdomen, including the whole litter as well as the maternal kidneys (Fig 3B white arrow) with a clear view of the renal hilum (Fig 3B yellow ellipse) where the arterial input function (AIF) is taken. The AIF derived from the kidney hilum matches that of expected kidney transport dynamics (Fig 3C black). The kidney undergoes rapid “wash-in” uptake of the contrast agent with peak concentration occurring just minutes after injection. Followed by a rapid wash-out phase of the contrast agent in the kidney after nearly 350 seconds after Gd administration. On the other hand, the placental perfusion dynamics (Fig 3C blue) albeit much slower in their uptake, also illustrate a rapid uptake of contrast agent within the first few minutes after Gd administration, with the steepest slope of the placenta’s temporal concentration gradient occurring roughly at peak AIF following a single bolus Gd administration. After the initial Gd uptake, the placenta continues to take in more contrast agent at a slower rate throughout the rest of the imaging study. The initial placental Gd uptake dynamics, the “wash-in” dynamics, can be quantified by the steepest slope of the MR signal of each voxel.
Example dynamic contrast enhancement time series images for a single slice of a pregnant mouse at: A) E14.5 and E17.5 of the same pregnant dam. An example placenta indicated with a white arrow. B) DCE image of the kidney (white arrow) and renal hilum (yellow ellipse) and C) example arterial input functions and whole placenta perfusion trace. The renal hilum is the location from which the arterial input function was determined. Notice in C the sharp increase in kidney perfusion around 200 seconds compared to the steady increase seen in the placenta. Black arrows point the location of the steepest slope of the MR signal time course for the arterial input function (kidney hilum) and placenta. Red arrow indicates the timing of Gd contrast agent administration. The scale bars in A and B are two centimeters.
Voxel-wise steepest slope mapping revealed that the initial Gd uptake dynamics are not spatially homogenous. There are distinct regions within the placenta that demonstrate faster perfusion dynamics and our physiological threshold successfully localizes these differences into two regions: the high and low perfusion chamber. The placental development from E14.5 to E17.5 showed differential changes for these two distinct chambers (Fig 4A–4D). The steepest slopes, which reflects the fast initial Gd uptake dynamics, significantly increased (p < 0.0001) in the high perfusion chamber from E14.5 to E17.5 (Fig 4E) but this was not seen in the low perfusion chamber. When averaging across the entire placenta, the overall steepest slopes were not significantly different between E14.5 and E17.5. The increased steepest slope in the high perfusion chamber from E14.5 to E17.5 is not due to the increase in the AIF obtained from renal hilum. There is no statistically significant difference in AIF between E14.5 and E17.5 [Fig 4F]. This quality control confirms that our observation of the steepest slope increases from E14.5 to E17.5 in the high perfusion chamber are not driven by the global systemic increase of the blood intake dynamic for all visceral organs; but rather by the developmental growth of the placental blood intake dynamic in the high perfusion chamber of the placenta.
A and B) Steepest slope maps prior to physiological thresholding for E14.5 (A) and E17.5 (B) of the same litter. (HPC = High Perfusion Chamber, LPC = Low Perfusion Chamber, WP = Whole Placenta). C and D) Steepest slope maps after physiological thresholding for E14.5 (C) and E17.5 (D). Low perfusion voxels after thresholding use the winter blue-purple colormap while the high perfusion voxels are assigned the black-red colormap. E) Violin plots of the mean steepest slope parameter for the different placental chambers and the whole placenta. Although there is an average increase in the steepest slope parameter for the whole placenta and low perfusion chamber, statistical significance is only achieved for the high perfusion chamber. F) Violin plots of the steepest slope of the arterial input functions for each litter at E14.5 to E17.5. No significant increase in the max of the steepest slope ensures that differences in perfusion are not driven by changes in kidney perfusion dynamics (**** = p < 0.0001). Scale bar is two centimeters.
Characterization of placental development with quantitative placental perfusion MRI
Placental hemodynamic functions have prominent importance for placental health and substrate delivery to the growing fetus. The placental perfusion can be quantitatively mapped (Fig 5) from the steepest slopes (Fig 4) in a voxel-wise manner. (Fig 5A–5D) shows the voxel-wise perfusion maps of a single slice of the same mouse litter on E14.5 (Fig 5A and 5C) and then on E17.5 (Fig 5B and 5D), pre- (Fig 5A and 5B) and post- (Fig 5C and 5D) physiological thresholding.
A and B) Perfusion maps prior to physiological thresholding for E14.5 (A) and E17.5 (B) of the same litter. C and D) Perfusion maps after physiological thresholding for E14.5 (C) and E17.5 (D). Physiological thresholding successfully delineates the different perfusion zones visually seen in A and B. The low perfusion voxels after thresholding are assigned the blue-purple colormap while the high perfusion voxels are assigned the black-red colormap. E) Perfusion Zones are biologically correlated with different placental chambers. Namely, quantitative perfusion MRI reveals visualization of the Decidua (De), Junctional Zone (Jz), and the Labyrinth Zone (Lz). F) Violin plots of the mean perfusion for the whole placenta and the high and low perfusion chambers at E14.5 and E17.5. There is a statistically significant increase in mean perfusion in the high perfusion chamber from E14.5 to E17.5. (**** = p <0.0001). Scale bar is two centimeters.
On average there is an increase in total placental perfusion. The low perfusion chamber average perfusion increases by ~15.6 mL/min/100 mL from E14.5 to E17.5, whereas the high perfusion chamber average perfusion increases by ~24.97 mL/min/100 mL (Fig 5F). The peak perfusion in each chamber from E14.5 to E17.5 was statistically significant (p < 0.0001). The anatomical locations of the high and low perfusion chambers correlate with known placental anatomy (Fig 5E): the high perfusion chamber correlates with the labyrinth zone whereas the low perfusion chamber correlates with the decidua, separated by a strip of intermediate perfusion zone, correlated with the junction zone (Fig 5E). The high and low perfusion chambers isolated by our physiological thresholding model corresponded well with the location, size, and morphology of a healthy mouse placenta on E17.5 [37].
Longitudinal perfusion analysis can be performed at the litter-level or on the individual placentas. Fig 4A and 4B details average litter-wise (Fig 6A) and placenta-wise (Fig 6B) longitudinal analysis of the mean perfusion for the whole placenta, low perfusion chamber, and the high perfusion chamber. Placental tracking from E14.5 to E17.5 was done through visual inspection of the DCE-MRI time series, spatial location, orientation and size of the placenta were used to indicate a likely pairing. There is on average an increase in the mean perfusion within the high perfusion chamber for every placenta from E14.5 to E17.5. The slope of the linear best fit (Fig 6A and 6B) for litter wise analysis of the low, high perfusion chambers, as well as the whole placenta is 5.23 ± 2.67 mL/min/100 mL, 8.23 ± 3.15 mL/min/100mL, and 5.83 ± 2.23 mL/min/ 100 mL, respectively. The placenta wise linear best-fit (Fig 6B) has similar slopes to the litter wise fitting with 5.13 ± 0.97 mL/min/100 mL, 7.82 ± 1.2 mL/min/100mL and 5.64 ± 0.89 mL/min/100 mL for the low perfusion, high perfusion chamber, and whole placenta, respectively. The litter-wise linear best-fit and 95% confidence intervals (Fig 6A and 6B) contains much more overlap than placenta-wise analysis, indicating individual litters show variation in perfusion magnitude.
Longitudinal perfusion linear regression calculated per litter (A) and per placenta (B), split by the separate perfusion chambers. (HPC = High Perfusion Chamber, LPC = Low Perfusion Chamber, WP = Whole Placenta). Seen in all plots is a linear increase in the mean perfusion across all chambers and the whole placenta from E14.5 to E17.5. Note that near complete separation of development trends at the placenta level are washed out when averaging across litters. Shaded areas represent 95% confidence intervals. Notice that in both the litter wise data and the placenta wise data, the slope of the trendline is much higher for the high perfusion chamber. The slope for the whole placenta nearly follows that of the low perfusion chamber.
Probabilistic quantification of spatial perfusion patterns, apparent blood volume, and chamber volume
In addition to placental perfusion and perfusion dynamics, we further developed novel biomarkers based on the probabilistic distribution of perfusion across the mouse placenta. We have successfully modeled the placental perfusion by a Gaussian-mixture-modeling to de-convolve two unique probability density functions (PDFs) from the original distribution of the log-transformed perfusion distribution. These PDFs allow further quantification of how perfusion is spatially distributed across the entire placenta. Fig 5A and 5B illustrates example PDF overlaid on the original histogram of the perfusion distribution for the same placentas on E14.5 compared to that of the ones on E17.5. The histograms of the placental perfusion can be fitted with two distinct Gaussian distributions (Fig 7A and 7B)–the blue Gaussian distributions corresponding to the high perfusion compartments whereas the green Gaussian distributions corresponding to the low perfusion compartments. There is a noticeable increase in size and peak of the distribution positioned with a larger mean perfusion on E17.5 compared to that on E14.5, reflecting the increase in size of the high perfusion zone. This models the increase in size and vasculature of the labyrinth zone from E14.5 to E17.5. In addition, novel quantitative biomarkers can be extracted from PDFs for probabilistic quantification of placental development. Table 1 summarizes biomarkers isolated from the de-convolved Gaussian PDFs, describing the shape of the Gaussian distributions: the peak is the maximum height of each perfusion distribution, the half-width is the width of the distribution at half of the peak value, mu is the mean and sigma the standard deviation of the distribution, the area under the curve [AUC] is the trapezoidal numerical integration of each distribution function.
Probability density functions (PDFs) calculated from histogram estimations for the distribution of perfusion values within the whole mouse placenta on E14.5 (A) and E17.5 (B). The shape of the distribution suggests the presence of two separate PDFs, one for the two main perfusion chambers. The development from E14.5 to E17.5 demonstrates an increase in the size of the high perfusion distribution (blue PDF). The two separate distributions were successfully deconvolved and parametrized using Gaussian Mixture Modeling. C) There is a statistically significant increase in the apparent blood volume in the whole placenta and both perfusion chambers from E14.5 and E17.5. D) Box and violin plot illustrating the slight, yet statistically significant increase in placental volume from E14.5 to E17.5. E) Lastly, there is a statistically significant increase in the ratio of the high perfusion chamber to the low perfusion chamber from E14.5 to E17.5. This nicely illustrates the selective increase in chamber size for the high perfusion region from E14.5 to E17.5. (* = p < 0.05, *** = p < 0.001, **** = p < 0.0001).
The biggest differences from E14.5 to E17.5 can be seen in the peak low and high parameters as well as the AUC (area under the curve) of the two distributions.
The size of the PDF is proportional to the volume of the placenta and the amount of blood flowing through the placenta over the imaging period. Therefore, the apparent total blood volume (ABV]) can be estimated by integration of the perfusion histograms (Fig 7C). The integration of the high perfusion histograms (Fig 7A and 7B, blue) represents the ABV of the high perfusion chamber, whereas the integration of the low perfusion histograms (Fig 7A and 7B, green) represents the ABV of the low perfusion chamber. This method revealed a statistically significant increase in ABV in the whole placenta, as well as the high and low perfusion chambers (Fig 5C). This result is driven both by the increase in overall placental perfusion from E14.5 to E17.5 (Fig 5) as well as the increase in placental size from E14.5 to E17.5. Fig 7D and 7E summarizes placental volume findings from our model. There is a statistically significant increase in the average size of the whole placenta from E14.5 to E17.5 (Fig 7D). Further, the volumetric ratios (Fig 5E) of the high perfusion chamber to the low perfusion chamber show a statistically significant increase (p < 0.0001). The average size percentage of the low perfusion zone on E14.5 is 54.2% ± 13.1% and 45.8% ± 13.2% for the high perfusion chamber. We observed a similar shift as described by Coan et al (22) for the decidua and labyrinth zone, where the low perfusion chamber’s mean size percentage is 42.8% ± 14.0% at E17.5 whereas the high perfusion chamber’s mean size percentage was 57.2% ± 14.1%.
Spatial distribution of apparent gd uptake correlates with perfusion MRI
We furthered our physiological-based chamber model with the longitudinal relaxation rate R1 which is the inverse of the longitudinal relaxation constant T1. The change in tissue R1 is proportional to the Gd accumulation. Thus, changes in placenta R1 due to Gd accumulation reflects the substrate delivery and accumulation in the placenta over the imaging period (~900 seconds). Fig 8 illustrates R1 maps on E14.5 (Fig 8A and 8C) and on E17.5 (Fig 8B and 8D) before (Fig 8A and 8B) or after (Fig 8C and 8D) physiological thresholding. We have successfully distinguished the high and low compartments in the quantitative R1 space. R1 maps revealed spatially distinguished compartments of similar sizes and locations as the high and low perfusion chambers delineated by the steepest slope (Fig 4) and perfusion (Fig 5) maps. Longitudinally, there is a statistically significant increase in the apparent Gd taken up by the whole placenta (Fig 8E) (p = 0.247), the low (p < 0.0001) and the high perfusion chambers (p < 0.001) from E14.5 to E17.5 (Fig 8E). These findings match the trends seen in the changes in average apparent peak perfusion.
A and B) Quantitative R1 maps prior to physiological thresholding for A) E14.5 and B) E17.5. C and D) the same R1 maps after physiological thresholding for C) E14.5 and D) E17.5. Physiological thresholding is again able to deconvolve different chambers in the placenta in the R1 space. The change in R1 is calculated pre- and post- administration of contrast agent and the apparent Gd uptake is estimated after normalizing by placental-chamber volume. E) Violin plots for of the average apparent Gd uptake for each placenta, separated by chamber as well as embryonic age. (HPC = High Perfusion Chamber, LPC = Low Perfusion Chamber, WP = Whole Placenta). There is a statistically significant increase in the Gd uptake for the whole placentas as well as the low perfusion chamber from E14.5 to E17.5. This is not seen in the high perfusion chamber. (* = p < 0.05, **** = p < 0.0001). Scale bar is two centimeters.
Discussion
Uterine contractile motion
The skew of contractile motion present at E17.5 compared E14.5 behooves the idea that this phenomenon may be a result of late-term contractions associated with pregnancy. Embryonic age 17.5 in the mouse is analogous to the late third trimester in human pregnancy [40,41], where spontaneous Braxton-Hick’s contractions are often reported [30–32]. Further, Gravina et al. [22] performed an extensive electrophysiological study into cervical, vaginal, and uterine tissues isolated from late-pregnant mice (E17 to E19) and found spontaneous, phasic contractions in all. Additionally, Nyquist sampling theory tells us that the highest frequency we can resolve without aliasing is half the temporal sampling frequency. The average respiration rate of anesthetized adult mice is ~80 breaths per minute or ~1.3 Hz, whereas the average heart rate of an anesthetized mouse is ~400 beats per minute or ~6.7 Hz. The temporal sampling frequency of our DCE-MRI protocol is ~18 seconds, or 55.6 mHz. Thus, the highest frequency in the motion time courses we can resolve is half of our sampling rate at 27.8 mHz. This is drastically smaller than the frequency of anesthetized adult mice respiration and heart rate, 27.8 mHz vs 1.3 and 6.7 Hz, respectively.
One observation from our in utero contractile analysis was the asymmetric nature of apparent contractions. Increases in average velocity and changes in spectral density and time-frequency power heavily indicate a spatial patterning of contractile movement. Our observation of spatial patterning could be a result of spatially inhomogeneous contractions of the placenta or that the contractions are from a different tissue source and the spatial inhomogeneity seen in the placenta is a result of differential contractile propagation across differing uterine tissues. In future studies we will consider other uterine tissues and utilize signal processing tools to localize the origin of apparent uterine contraction to further characterize our observation.
The observed contractile phenomenon has variable effects across this entire analysis and our model. The steepest-slope modeling itself does not result in time-series perfusion maps, rather a temporal projection from a single frame where the steepest-slope of the imaging signal is calculated for every voxel of every slice in the time-series. However, if extreme motion is present, this could result in misleadingly high steepest-slope values because of placental contrast moving in and out of the imaging plane. Therefore, prior to determination of the steepest-slope map from the kinetic time-series data, the DCE time series were motion-corrected and spatially median filtered. Spatial median filtering was performed using a kernel of size 3 x 3 x 3 and the built-in MATLAB [Mathworks, R2019A] function medfilt3.As a result, the projection and estimation of the perfusion is not based on steady-state averages, but dynamics calculated for a single time, meaning that motion across the entire time-series does not play a role in steepest-slope and perfusion estimation. Therefore, after applying simple motion correction through spatial median filtering, the parameters of this model including steepest-slope quantification, mean perfusion, and probability density function estimation are unaffected by the uterine contractions.
Perfusion trace waveform and placental volume are two metrics that must be specially handled because of uterine contractions. To prevent incorrect morphology of the perfusion trace for the placenta and corresponding chamber, perfusion traces were developed using full time series segmentations, where each perfusion time point was estimated by averaging the intensity values across the placenta and then across the different placental chambers. This difference in analysis methods was chosen to minimize the introduction of low-frequency filtering artifacts to the perfusion traces, which could alter perfusion trace metrics such as apparent blood volume estimation. Further, the magnitude of artifacts that may be introduced to the perfusion curves are much smaller than the magnitude of the steepest slope. Thus, the perfusion curves were estimated slice-wise by averaging across a given segmentation at a given time for the entire time-series datasets. This observation and corresponding correction are crucial to consider for implementing this model for other studies as the motion on E17.5 may result in incorrect interpretations of physiological function.
Physiological thresholding demonstrates spatial variance of placental chambers across multiple perfusion MRI domains
Although the identification of spatially varying perfusion zones within the mouse placenta has been identified in other studies [39,42–45], we expanded this knowledge with the addition of a biologically based [22] modeling for automatic localization of the different perfusion chambers. All other previous studies rely on manual analysis and region of interest [ROI] generation after data review. Instead, our group used a numerical threshold of the perfusion probability density function to localize the different perfusion chambers. We have presented a successful physiological model of placental perfusion development and motion dynamics for the mouse placenta by expanding on steepest-slope perfusion modeling and utilizing a physio-anatomical foundation for modeling the different placental chambers in quantitative perfusion MRI studies. Our model of the placental chambers and quantification of their physiological differences follows the expected development based on biomolecular studies of decidua and labyrinth formation [46]. This is the first study of placental chamber formation that crosses from the quantitative perfusion space to other metrics of MR imaging. The same physio-anatomical thresholding method was utilized in the steepest-slope, apparent perfusion, and the quantitative R1 spaces. As the steepest-slope, average apparent perfusion, and R1 space elicit different meanings: instantaneous perfusion rate, average apparent peak perfusion, and local apparent gadolinium uptake (AGU), respectively. The AGU estimates the amount of substrate delivery into the placenta using the change in tissue relaxation [T1/R1] time due to Gd uptake. Specifically, changes in AGU demonstrate that the “wash-in” and “wash-out” mechanisms of the mouse placenta show differential kinetics across the various perfusion chambers and across embryonic age. Models of placental disease may elicit differences in one or more, or a combination thereof the different perfusion metrics within each perfusion chamber.
Further, contributions from each de-convolved perfusion PDF follows the proportions defined within our physiological thresholding method. This method combined with a model for the automated segmentation of the placenta within the DCE time-series would provide a full pipeline for automated chamber perfusion analysis.
An important characteristic of the methods and models developed in this paper is the non-invasive nature of image acquisition. The ability to non-invasively estimate important physiological parameters, such as mean apparent perfusion and apparent total blood volume, provides robust and quantitative biomarkers for longitudinal investigation of placental development of multi-fetal mouse pregnancy to complement the molecular and mechanistic investigation in preclinical mouse models. It also has a higher potential for clinical translation of the described methods. Many development associated diseases and disorders lack biomarkers that can effectively predict the variation of disease outcomes [7,47–50]. In addition, many congenital disorders and placental related conditions showed incomplete penetrance and variable outcomes. The underlying mechanisms for the variable phenotypical presentations cannot be understood without sensitive differential phenotyping tools. This major knowledge gap can be addressed by combining longitudinal functional MRI methods with invasive, molecular investigations. Such an investigation has the potential to drastically increase our understanding of developmental disorders, and our methods serve as a crucial support.
Future work will employ quantitative methods to correctly identify each placenta for successful longitudinal mouse imaging with multi-fetal pregnancy. Mouse uterine horns are doubly perfused by the uterine branch of the ovarian artery and the distal part of the uterine artery [51,52]. A bi-directional arterial spin labeling (BD-ASL) approach [52,53] can determine fetal/placental positions along each uterine horn. By saturating the proton spins in the incoming arterial blood in the uterine and ovary arteries, which dually perfuse each placenta-fetal unit, changes in placental signals correlated with its position along the uterine horn.
Importance of the placental perfusion development program and pregnancy monitoring
The dramatic changes in placental function from E14.5 to E17.5 further illustrate how the placenta should be an important consideration when studying fetal physiology and neurodevelopment. Studies that do not take the time to consider the different contributions of each placental chamber therefore may not consider the full picture. The dramatic changes in the labyrinth zone as modeled by the high perfusion chamber have the potential to be vital to overall fetal development, in particular, neurodevelopment. In the future, we will use this model to quantify placental perfusion dynamics in various neurodevelopmental disorders, with the hypothesis that alterations in labyrinth zone perfusion dynamics are present in abnormal developing fetuses. We expect to see alterations in the default development program described in this study. If placental development is interrupted, the increase in perfusion, spatial patterning of perfusion, and/or end-term contractions may all demonstrate different dynamics with the potential of shining light on unanswered questions in fetal development diseases and disorders.
Our proposed DCE-MRI pipeline may also be used to monitor pregnancy development and provide functional information for placental health in combination with other markers to create a comprehensive imaging panel for monitoring both mother and fetal health. Suarez et al. performed a longitudinal study of pregnancy-induced remodeling of the murine reproductive tract using various MRI biomarkers. The combination of remodeling of the vagina, cervix, uterine horns and placental perfusion, substrate delivery rate, and substrate accumulation would be a powerful imaging tool for advanced diagnostics and monitoring.
Conclusion
In summary, we have developed an in-vivo pipeline for the longitudinal analysis of placental perfusion and uterine-related contractions. We demonstrate the capabilities of the steepest-slope modeling method for peak perfusion estimation from subcutaneous (subQ) injection of Gd contrast agent that appropriates dam health over multiple injections. We expand the perfusion chamber paradigm for the mouse placenta via novel use of a physiologically based threshold for delineation of the separate systems. We apply this methodology to two metrics not previously reported, the steepest slope of the perfusion time course, and the apparent Gd uptake. The latter of which is a function of the change in longitudinal relaxation pre- and post Gd administration. We have shown that the placenta’s anatomical chambers are defined not just by peak perfusion, but also the instantaneous change in perfusion and total Gd contribution from the vascular system.
Notably our application of computer vision and digital signal processing are the first to quantify contraction-related motion non-invasively, in-vivo. We use these tools to show that the mouse placenta exhibits asymmetric motion due to in-utero contractions, with most of the motion localized to the high perfusion chamber. We have expanded the researcher’s toolbox to investigate these contractions in combination with drugs known to modulate pregnancy hormones, contractions, and labor.
Methods
Animals
All mice used in the study were inbred C57BL/6J wild-type (WT) mice obtained from Jax Lab (Jax Stock No. 000664). Mice were housed in the AALAS certified animal vivarium in the Rangos Research Center with full-time AALAS certified technicians for husbandry care under the university Division of Laboratory Animal Resources (DLAR). Full-time veterinary care was provided by university DVMs. Mice were provided with food and water ad libitum and kept on a 12:12 hour dark/light cycle. Once weaned at 28 days, male or female littermates were housed with 2–4 mice per cage until 3 and a half months of age for experiments. Timed pregnancy was determined by the presence of vaginal plugs after crossing a male and a female in the same cage overnight. Ten pregnant females with 70 placentas were examined. Bodyweights of the pregnant females on E14.5 and E17.5 were 28.32 ± 1.58 g and 33.16 ± 1.69 g respectively. All animals received humane care in compliance with the Guide for the Care and Use of Laboratory Animals1. All experiments were conducted with approval by the University of Pittsburgh Institutional Animal Care and Use Committee (IACUC) according to the protocol number #22010634. No pain or distress was expected for in vivo MRI experiments which entails conducting noninvasive imaging of mice under inhalable anesthesia with isoflurane. A subcutaneous clinical grade sterile catheter for contrast agent injection was inserted and removed under anesthesia, which was classified as USDA category C, therefore no analgesia was needed. At the endpoint, all animals were euthanized before harvesting the placenta and fetuses for further tissue analysis. Mice were euthanized by inhaling 5% isoflurane for more than 10 minutes. After the animal was deeply anesthetized and has lost response to leg or tail pinch, cervical translocation was then performed to complete euthanasia.
Anesthesia for in vivo MRI
All mice received general inhalation anesthesia with Isoflurane for in vivo imaging. The mice were placed into a clear Plexiglas anesthesia induction box that allows unimpeded visual monitoring of the animals. Induction was achieved by administration of 3% Isoflurane mixed with oxygen for a few minutes. Depth of anesthesia was monitored by toe reflex (extension of limbs, spine positioning) and respiration rate. Once the plane of anesthesia was established, it was maintained with 1–2% Isoflurane in oxygen via a designated nose cone and the mouse was transferred to the designated animal bed for imaging. Respiration was monitored using a pneumatic sensor placed between the animal bed and the mouse’s abdomen while rectal temperature was measured with a fiber optic sensor and maintained with feedback-controlled warm air source (SA Instruments, Stony Brook, NY, USA).
Single bolus gadolinium (Gd) contrast agent administration
A 24-gauge sterile subcutaneous catheter (McKesson Medical-Surgical Inc. Richmond, VA) was inserted into the dorsal subcutaneous space between the back skin and the muscle. A single bolus of Gd (0.1 mmol/kg bodyweight, using 1:10 dilution of Multihance, Gadobenate dimeglumine injection solution, 529 mg/ml, Bracco Diagnostics, Inc. Monroe Twp, NJ) was administered between time frames 4 and 5 via the subcutaneous catheter during the dynamic contrast enhancement (DCE) MRI acquisition.
In vivo MRI acquisition
In vivo MRI was carried out on a Bruker BioSpec 70/30 USR spectrometer (Bruker BioSpin MRI, Billerica, MA, USA) operating at 7-Tesla field strength, equipped with an actively shielded gradient system, using a quadrature radio-frequency volume coil with an inner-diameter of 35 mm for transmission and reception.
For dynamic contrast enhancement (DCE), multi-planar T1-weighted dynamic time series was acquired using free-breathing-no-gating IntraGate fast gradient echo sequence with retrospective motion deconvolution using the following parameters: field of view (FOV) = 4.0 cm X 2.5 cm, matrix = 256 X 160, slice thickness = 0.85 mm, in-plane resolution = 0.156 mm, echo time (TE) = 1.872 msec, repetition time (TR) = 101.493 msec, flip angle (FA) = 75°, number of repetition (NR) = 1, acquisition time = 10 sec 120 msec.
R1 mapping was achieved by varied multiple flip angles. Five multi-planar IntraGate image stacks were acquired using the following parameters: FOV = 4.0 cm X 2.5 cm, matrix = 256 X 160, slice thickness = 0.85 mm, in-plane resolution = 0.156 mm, TE = 1.872 msec, TR = 114.88 msec, 5 flip angle FA = 75°, 55°, 30°, 20°, and 10°, NR = 10, acquisition time = 1 min 33 sec 904 msec.
Image pre-processing and segmentation
Prior to quantitative analysis, temporal morphological closing was performed to remove any potential motion artifacts. Spatial median filtering was applied to each image in the time-series for further removal of motion artifacts and smoothing of high-frequency noise. At this point steepest-slope modeling was performed. Finally, a mean-removed maximum intensity projection [MIP] was created from the DCE time-series for each slice. The mean kinetic image was calculated by averaging MR images acquired during the initial uptake phase of the administered gadolinium. The result was a 256 by 160 by 20 slice image-matrix. This matrix was output to ITK-snap where manual segmentation of each placenta in the litter was performed. The segmentations were masked on the perfusion maps of each animal, and all quantification was then performed.
Kinetic time series of each slice were also created, resulting in a 256 by 160 by 50 time series image-matrix. These matrices were exported to ITK-snap (Penn Image Computing and Science Laboratory, Version 4.0) where manual segmentation of the placenta was performed. These secondary masks were used to produce all time-series traces. ITK-snap is an open-source software that enables the manual and semi-automatic segmentation of 3D and 4D biomedical images.
The final quantitative R1 maps pre- and post- contrast agent were also output to ITK-snap where manual segmentation was again performed. These segmentations were used for R1 and Gd metrics as well as to calculate placental volume.
Quantitative R1 mapping and apparent Gd quantification
Gadolinium-based contrast agents alter the longitudinal relaxation time associated with proton spin that is responsible for the MRI signal [54], this longitudinal relaxation time is also known as T1. The paramagnetic properties of Gd decrease the T1 relaxation time for a given tissue. The inverse of T1 is known as R1 and is measured in Hz, with an increase in tissue R1 being directly proportional to the apparent amount of Gd taken up by the tissue of interest. Similar metrics looking at changes in tissue relaxation times due to Gd uptake can be seen in studies that quantify extracellular volume by scaling changes in R1 by the subject’s hematocrit level [55–57]. Changes in placenta R1 due to Gd accumulation reflects the substrate delivery and accumulation in the placenta. Therefore, determining the change in R1 pre- and post- contrast can be used to further understand development of material-transfer systems in placental tissue. To determine the total apparent Gd placental uptake, T1 relaxation quantification was carried out for each litter pre- and post- administration of the contrast agent using the varied-flip angle method [58]. The varied flip-angle method utilizes the relationship between the steady-state MR signal SMR and T1/TR as described by the Ernst Equation:
Eq [1]
This equation is linearized with slope E1 and T1 can be extracted from the slope via the following:
Eq [2]
The slope, E1 is numerically determined from the Intragate FLASH image data via a least-squares based nonlinear fitting of Eq 1. Intragate FLASH imaging was utilized with flip angles of 75, 55, 30, 20, and 10 degrees. Imaging parameters included TE/TR = 1.872/114.8 ms with 10 repetitions. The field of view was set to 40 x 25 mm with a matrix of 256 x 160 for a final resolution of 0.156 mm/pixel by 0.156mm/pixel. Varied Flip Angle imaging was performed directly prior to subcutaneous administration of the contrast agent and directly after perfusion kinetic imaging was completed.
Finally, the AGU was estimated using the following equation that relates the change in R1 pre- and post-contrast to the volume of the placenta and its corresponding chambers.
Perfusion estimation via the steepest slope model
The steepest slope of a given voxel intensity gradient represents a faster increase in local concentrations of administered contrast agent. The steepest slope modelling schema is a one-parameter model to estimate instantaneous tissue perfusion using DCE-MRI. Brix et al. [38] provide a comprehensive review of the steepest slope model as a tool for tissue perfusion estimation and clinical efficacy. The tissue concentration of Gd during initial wash-in is represented by the following equation:
Eq [3]
Where CT is the Gd tissue concentration, M[t] is the mass of the Gd in the placental volume. VP and VI represent the ratios of intravascular and interstitial spaces of the placenta, respectively. Finally, CP and CI are the Gd tissue concentrations in the respective intravascular and interstitial spaces.
Further, assuming Gd travels in the blood with plasma flow F, then the mass gradient over time of Gd within the placenta can be described by Fick’s Principle [59]. Fick’s principle states that the calculation for blood flow to a given tissue can be calculated if the Gd concentration at the arterial tissue input, the venous tissue output, and the amount taken up by the organ is known. Incorporating plasma flow F, the mass-gradient of the Gd over time becomes:
Eq [4]
Where CA is the tissue arterial input function (AIF), and CV is the venous output. Finally, by assuming that no venous wash-out occurs during uptake of Gd, the concentration-gradient of the contrast agent over time becomes:
Eq [5]
It can now be seen that Eq [5] provides a relationship between the perfusion in the tissue over time and the concentration of the administered Gd. Final perfusion value for each voxel is then calculated as the max perfusion of the voxel over time. Therefore Eq [5] reaches a maximum when the left-hand side reaches its maxima.
The arterial input to the placental chambers is taken from the kidney renal hilum of each litter mother. A small region is hand-annotated over the renal hilum and the corresponding AIF is produced from each DCE time-series MRI image. The change in contrast agent over time is estimated from the raw DCE time-series images for every voxel. The voxel-time point with the greatest estimated change is kept and divided by the max of the AIF, as described by Eq 6. This process reduces the dimensionality of the time-series DCE to a single map of tissue perfusion. This process is repeated for every 2D-DCE slice taken to produce a final 3D perfusion map.
Physiological thresholding of the mouse placenta into perfusion chambers
The identification of separate perfusion chambers in the mouse placenta via DCE-based MRI has been shown in several other studies that correlate the perfusion chambers with the decidua and labyrinth [39–41]. These zones are anatomically and physiologically defined and separated by a junction-protein dense membrane to regulate endocrine crosstalk between the two regions [54]. A main function of the labyrinth zone is to mediate nutrient and waste exchange between the maternal blood and the amniotic fluid of the embryo [54]. The labyrinth zone contains maternal blood sinusoids that interface with fetal blood vessels in the form of a dense network of vessels that utilize counter-current blood flow for rapid nutrient exchange. The extensive surface area of this network makes it a dense blood highway with increased perfusion compared to the decidua and junctional zone [54].
Coan et al [37], have performed an exhaustive stereology-based analysis of the volume of various placental chambers. They performed the analysis for E14.5, E16.5, and E18.5 litters. Estimation of E17.5 was performed by averaging the results for E16.5 and E18.5. They conclude that at E14.5, the labyrinth zone takes up roughly 45% of placental volume and 55% is taken by the decidua and junctional zone. These proportions switch on E17.5, however, and roughly 55% of the volume is taken up by the labyrinth zone. Therefore, automatic localization of each the different perfusion chambers in each segmented placenta is performed by calculating the 55th and 45th percentile of placental perfusion values on E14.5 and E17.5, respectively. Any voxels below this threshold are deemed in the ‘Low Perfusion Chamber’ and voxels above deemed in the ‘High Perfusion Chamber.’
Perfusion dynamics
The steepest slope-model’s single parameter is the peak of the gradient of concentration of the administered contrast agent through the placental chambers. After thresholding, this parameter was collected from each voxel from E14.5 to E17.5. The average perfusion value of the different placental chambers and whole placenta was also calculated for the different groups. Apparent total blood volume through the placenta was estimated via the following equation:
Eq [7]
Where 1/N is the size of the placenta calculated as the number of voxels in the segmentation mask. H[n] is the probability density function of the placental perfusion. ABV was calculated for the high and low perfusion chambers after physiological thresholding using the same equation. This method was implemented numerically using trapezoidal estimation of the area under the perfusion trace.
Numerical modeling using gaussian mixture modeling
The Probability Density Function was first estimated using histogram functions in MATLAB. The PDF was estimated from the perfusion values for all voxels in the segmented placentas for each litter. The histograms were Log-base-10 transformed to achieve a more normal probability distribution. Then, a two-component Gaussian mixture model was used to estimate and parameterize the true PDFs from the histogram estimates. The Expectation-Maximization algorithm [60] (EM) was implemented via built-in MATLAB functions to estimate the probability parameters θ: = π, μ1, σ1, μ2, σ2 of the perfusion distribution. The EM algorithm is a method for determining the maximum likelihood estimate (MLE) of the unknown probabilistic parameters. The EM algorithm maximizes the marginal likelihood of observed data:
Eq [8]
Where X is the observed perfusion values of each voxel in each placenta, Theta is a vector representing the PDF parameters mu and sigma, and Z is unobserved or missing values. As Z is generally indescribable, the EM algorithm solves this problem by first randomly initializing θ, and assigning each point to the two PDFs defined by its parameters. Then performing an expectation step by computing the responsibilities of each point to its corresponding PDF. θ is then updated via the maximum-likelihood formulas. The overall algorithm is described in detail below:
- Random initialization of θ,
- Expectation is performed via computation of the contribution of each data point to the two initial clusters:
Eq [9]
- Maximization is performed and the parameters defined with θ are updated via weighting of the new parameters by γi
Eq [10]
- Steps two and three are repeated until convergence is reached.
After computing the parameter mu and sigma for each Gaussian component, features of the distributions were computed as potential biomarkers for placental development. For each distribution the following metrics were collected: area under the curve, the half-height, the full width at half maximum (FWHM) and peak value.
Quantification of placental motion
Exploratory analysis of DCE time-series images revealed extensive placenta motion, specifically at E17.5, after normal motion correction was applied. This motion was quantified using a mathematical model of vision known as optical flow [61,62]. We utilize the Horn-Shuck [HS] method of solving the optic flow aperture problem to quantify the apparent motion across our DCE time series. The HS optic flow method was implemented to estimate placental motion in each slice of the DCE time-series images using built-in MATLAB functions. The regularization parameter that controls the expected smoothness of the input was set to 102. The HS optical flow method results in a dense vector field that contains velocity vector information for every voxel at every time point. The time-series segmentations used to extract perfusion traces are also used to extract average velocity traces for each whole placenta, the low perfusion, and the high perfusion chambers. Average velocity magnitude for each traces was computed and compared across the whole placenta and corresponding perfusion chambers.
Power spectral density estimation and time-frequency analysis of placental motion
The spectrogram and periodogram were both used to quantify frequency and spectral characteristics of uterine contraction velocity. The periodogram is an estimation of the power spectral density (PSD) of a given signal. In other words, the periodogram is an estimate of the frequency power per unit of frequency. Formally, it is mathematically in a continuous sense defined as the Fourier transform of the autocorrelation of the signal, as described by the following equation.
Where F is the Fourier transform operator and * is the correlation operator. However, this definition cannot be used for discreate data and must be estimated using time-averaging. Various methods have been developed for this estimation, but in this study Welch’s method [63] is implemented using built-in MATLAB functions.
The spectrogram is a tool for performing time-frequency analysis that is, seeing how frequency power of a signal changes over the time course of the signal. The result is a two-dimensional matrix where each value in the matrix represents the power at a given frequency at a given time. In words, this is calculated by windowing a signal into segments with or without overlap and calculating the frequency power of that segment. The length of the window and amount of overlap controls the resolution in the time domain. In practice, this is implemented using a signal processing tool known as the Discrete short-time Fourier transform (Discrete STFT). The Discrete STFT can be calculated using the following equation:
Eq [12]
Further, the magnitude-squared of the equation above is formally known as the spectrogram:
Eq [13]
In this study, the above is implemented using built-in MATLAB functions. A 15-sample Bartlett window with 50% overlap between segments was used for the window, and the size of the fast-Fourier transform (FFT) was ten times the length of the DCE time-series.
Both above analytical efforts revealed the most frequency power and spectral density at and around the 10 mHz frequency band. Therefore, as our last effort into exploring this phenomenon, the periodogram was calculated for every voxel of the time-series images. Then, the relative power in the sub-band from 8 to 12 mHz was calculated. Finally, the relative power spectrum of the 8–12 mHz sub band was computed as a ratio to the total power in the entire spectrum range for each voxel in the DCE-time series and viewed as a spectral density projection map of the time series.
Statistics
Unpaired t-tests with unequal variances were performed for comparisons between two groups. One-way ANOVA was utilized for all other statistical analysis with Tukey-Kramer tests used for all ad-hoc testing. Statistical analysis performed using Prism 9 graphing and statistical software package.
Contributions
DREC implemented and performed all image analysis, in charge of paper drafting and review, responsible for conception of physiological thresholding and conception of probabilistic quantification as well as time-frequency analysis. KES acquired MRI data. MCS and NWC were responsible for timing mouse pregnancy, colony management, and assisted with data analysis. DW performed ROI segmentation and analysis. MGO and RWP assisted with concept formation and study design. YLW is responsible for overall study design, conceptual formation, establishing protocols, training and supervising research personnel, data acquisition, and overseeing all aspects of the study.
Acknowledgments
The authors wish to thank Ms. Caitlin Swanberg for participating in the preliminary testing phase.
References
- 1. Sandovici I., et al., Placental adaptations to the maternal-fetal environment: implications for fetal growth and developmental programming. Reprod Biomed Online, 2012. 25[1]: p. 68–89. pmid:22560117
- 2. Shallie P.D. and Naicker T., The placenta as a window to the brain: A review on the role of placental markers in prenatal programming of neurodevelopment. Int J Dev Neurosci, 2019. 73: p. 41–49. pmid:30634053
- 3. Ilekis J.V., et al., Placental origins of adverse pregnancy outcomes: potential molecular targets: an Executive Workshop Summary of the Eunice Kennedy Shriver National Institute of Child Health and Human Development. Am J Obstet Gynecol, 2016. 215[1 Suppl]: p. S1–s46. pmid:26972897
- 4. Bukowski R., et al., Altered fetal growth, placental abnormalities, and stillbirth. PLoS One, 2017. 12[8]: p. e0182874. pmid:28820889
- 5. Monk D., Genomic imprinting in the human placenta. Am J Obstet Gynecol, 2015. 213[4 Suppl]: p. S152–62. pmid:26428495
- 6. Goldberg C.S., et al., Neurodevelopment and quality of life for children with hypoplastic left heart syndrome: current knowns and unknowns. Cardiol Young, 2011. 21 Suppl 2[0 2]: p. 88–92. pmid:22152534
- 7. Laraja K., et al., Neurodevelopmental Outcome in Children after Fetal Cardiac Intervention for Aortic Stenosis with Evolving Hypoplastic Left Heart Syndrome. J Pediatr, 2017. 184: p. 130–136.e4. pmid:28233547
- 8. Mahle W.T. and Wernovsky G., Neurodevelopmental outcomes in hypoplastic left heart syndrome. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, 2004. 7: p. 39–47. pmid:15283351
- 9. Hemberger M., Hanna C.W., and Dean W., Mechanisms of early placental development in mouse and humans. Nat Rev Genet, 2020. 21[1]: p. 27–43. pmid:31534202
- 10. Woods L., Perez-Garcia V., and Hemberger M., Regulation of Placental Development and Its Impact on Fetal Growth-New Insights From Mouse Models. Front Endocrinol [Lausanne], 2018. 9: p. 570. pmid:30319550
- 11. Avni R., Neeman M., and Garbow J.R., Functional MRI of the placenta—From rodents to humans. Placenta, 2015. 36[6]: p. 615–22. pmid:25916594
- 12. Ma Y., Zhang L., and Huang X., Genome modification by CRISPR/Cas9. Febs j, 2014. 281[23]: p. 5186–93. pmid:25315507
- 13. Hartenian E. and Doench J.G., Genetic screens and functional genomics using CRISPR/Cas9 technology. Febs j, 2015. 282[8]: p. 1383–93. pmid:25728500
- 14. Ishino Y., Krupovic M., and Forterre P., History of CRISPR-Cas from Encounter with a Mysterious Repeated Sequence to Genome Editing Technology. J Bacteriol, 2018. 200[7]. pmid:29358495
- 15. Blake J.A., et al., The Mouse Genome Database: integration of and access to knowledge about the laboratory mouse. Nucleic Acids Res, 2014. 42[Database issue]: p. D810–7. pmid:24285300
- 16. Bult C.J., et al., The Mouse Genome Database [MGD]: mouse biology and model systems. Nucleic Acids Res, 2008. 36[Database issue]: p. D724–8. pmid:18158299
- 17. Austin C.P., et al., The knockout mouse project. Nat Genet, 2004. 36[9]: p. 921–4. pmid:15340423
- 18. Muñoz-Fuentes V., et al., The International Mouse Phenotyping Consortium [IMPC]: a functional catalogue of the mammalian genome that informs conservation. Conserv Genet, 2018. 19[4]: p. 995–1005. pmid:30100824
- 19. Cacheiro P., Haendel M.A., and Smedley D., New models for human disease from the International Mouse Phenotyping Consortium. Mamm Genome, 2019. 30[5–6]: p. 143–150. pmid:31127358
- 20.
Hutchison J, Mahdy H, Hutchison J. Stages of Labor. [Updated 2023 Jan 30]. In: StatPearls [Internet]. Treasure Island [FL]: StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK544290/.
- 21. Mitchell BF, and Taggart MJ. Are animal models relevant to key aspects of human parturition? American journal of physiology Regulatory, integrative and comparative physiology. 2009;297[3]:R525–45. pmid:19515978
- 22. Gravina FS, van Helden DF, Kerr KP, de Oliveira RB, and Jobling P. Phasic contractions of the mouse vagina and cervix at different phases of the estrus cycle and during late pregnancy. PloS one. 2014;9[10]:e111307. pmid:25337931
- 23. Malik M, Roh M, England SK. Uterine contractions in rodent models and humans. Acta Physiol [Oxf]. 2021 Apr;231[4]:e13607. Epub 2021 Jan 7. pmid:33337577; PMCID: PMC8047897.
- 24.
Gill P, Patel A, Van Hook JW. Uterine Atony. [Updated 2023 Feb 6]. In: StatPearls [Internet]. Treasure Island [FL]: StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK493238/.
- 25. Malik M, Roh M, and England SK. Uterine contractions in rodent models and humans. Acta Physiol [Oxf]. 2021;231[4]:e13607. pmid:33337577
- 26. Kissler K, and Hurt KJ. The Pathophysiology of Labor Dystocia: Theme with Variations. Reproductive sciences [Thousand Oaks, Calif]. 2023;30[3]:729–42. pmid:35817950
- 27. Romero R, Dey SK, and Fisher SJ. Preterm labor: one syndrome, many causes. Science. 2014;345[6198]:760–5. pmid:25124429
- 28. Liu L, Johnson HL, Cousens S, Perin J, Scott S, Lawn JE, et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet [London, England]. 2012;379[9832]:2151–61. pmid:22579125
- 29. Blencowe H, Cousens S, Oestergaard MZ, Chou D, Moller AB, Narwal R, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet [London, England]. 2012;379[9832]:2162–72. pmid:22682464
- 30. Hicks JB. Contractions of the Uterus Throughout Pregnancy. Buffalo Med Surg J. 1887;27[3]:97–9. pmid:36668326
- 31. Raines DA, and Cooper DB. StatPearls. Treasure Island [FL]: StatPearls Publishing Copyright © 2023, StatPearls Publishing LLC.; 2023.
- 32. Bower S, Campbell S, Vyas S, and McGirr C. Braxton-Hicks contractions can alter uteroplacental perfusion. Ultrasound in obstetrics & gynecology: the official journal of the International Society of Ultrasound in Obstetrics and Gynecology. 1991;1[1]:46–9. pmid:12797102
- 33. Oosterhof H, Dijkstra K, and Aarnoudse JG. Uteroplacental Doppler velocimetry during Braxton Hicks’ contractions. Gynecol Obstet Invest. 1992;34[3]:155–8. pmid:1427416
- 34. Oosterhof H, Dijkstra K, and Aarnoudse JG. Fetal Doppler velocimetry in the internal carotid and umbilical artery during Braxton Hicks’ contractions. Early human development. 1992;30[1]:33–40. pmid:1396288
- 35. Napso T, Yong HEJ, Lopez-Tello J, Sferruzzi-Perri AN. The Role of Placental Hormones in Mediating Maternal Adaptations to Support Pregnancy and Lactation. Front Physiol. 2018 Aug 17;9:1091. pmid:30174608; PMCID: PMC6108594.
- 36. Mori M., et al. The decidua-the maternal bed embracing the embryo-maintains the pregnancy. Semin Immunopathol. 2016 Nov;38[6]:635–649. Epub 2016 Jun 10. pmid:27287066; PMCID: PMC5065593.
- 37. Philip M., Coan Anne C. Ferguson-Smith, Graham J. Burton, Developmental Dynamics of the Definitive Mouse Placenta Assessed by Stereology, Biology of Reproduction, Volume 70, Issue 6, 1 June 2004, Pages 1806–1813, https://doi.org/10.1095/biolreprod.103.024166.
- 38. Brix G., et al., Estimation of tissue perfusion by dynamic contrast-enhanced imaging: simulation-based evaluation of the steepest slope method. Eur Radiol, 2010. 20[9]: p. 2166–75. pmid:20407900
- 39. Kording F, Forkert ND, Sedlacik J, Adam G, Hecher K, Arck P, et al. Automatic differentiation of placental perfusion compartments by time-to-peak analysis in mice. Placenta. 2015 Mar;36[3]:255–61. Epub 2014 Dec 23. pmid:25575437.
- 40. Ander S. E., Diamond M. S., & Coyne C. B. [2019]. Immune responses at the maternal-fetal interface. Science Immunology, 4[31], eaat6114. pmid:30635356
- 41. Hemberger M., Hanna C. W., & Dean W. [2020]. Mechanisms of early placental development in mouse and humans. Nature Reviews Genetics, 21[1], 27–43. pmid:31534202
- 42. Yadav BK, Neelavalli J, Krishnamurthy U, Szalai G, Shen Y, Nayak NR, et al. A longitudinal study of placental perfusion using dynamic contrast enhanced magnetic resonance imaging in murine pregnancy. Placenta. 2016 Jul;43:90–7. Egpub 2016 Jan 4. pmid:26947613; PMCID: PMC5704953.
- 43. Bao Q., Hadas R., Markovic S. et al. Diffusion and perfusion MRI of normal, preeclamptic and growth-restricted mice models reveal clear fetoplacental differences. Sci Rep 10, 16380 [2020]. https://doi.org/10.1038/s41598-020-72885-9. pmid:33009455
- 44. Remus C. C., Sedlacik J., Wedegaertner U., Arck P., Hecher K., Adam G., et al. [2013]. Application of the steepest slope model reveals different perfusion territories within the mouse placenta. Placenta, 34[10], 899–906. pmid:23849931
- 45. Remus C. C., Kording F., Arck P., Solano E., Sedlacik J., Adam G., et al. [2018]. DCE MRI reveals early decreased and later increased placenta perfusion after a stress challenge during pregnancy in a mouse model. Placenta, 65, 15–19. https://doi.org/10.1016/j.placenta.2018.03.009.
- 46. Napso T, Yong HEJ, Lopez-Tello J, Sferruzzi-Perri AN. The Role of Placental Hormones in Mediating Maternal Adaptations to Support Pregnancy and Lactation. Front Physiol. 2018 Aug 17;9:1091. pmid:30174608; PMCID: PMC6108594.
- 47. Page J.M., Blue N.R., and Silver R.M., Fetal Growth and Stillbirth. Obstet Gynecol Clin North Am, 2021. 48[2]: p. 297–310. pmid:33972067
- 48. Matthiesen N.B., et al., Congenital Heart Defects and Indices of Placental and Fetal Growth in a Nationwide Study of 924 422 Liveborn Infants. Circulation, 2016. 134[20]: p. 1546–1556.
- 49. Pang Y., Lee C. M., Wright M., Shen J., Shen B., & Bo J. [2018]. Challenges of case identification and diagnosis of Autism Spectrum Disorders in China: A critical review of procedures, assessment, and diagnostic criteria. Research in Autism Spectrum Disorders, 53, 53–66. https://doi.org/10.1016/j.rasd.2018.06.003.
- 50. Nia S. Psychiatric signs and symptoms in treatable inborn errors of metabolism. J Neurol 261 [Suppl 2], 559–568 [2014]. https://doi.org/10.1007/s00415-014-7396-6. pmid:25145892
- 51. Vom Saal FS, and Dhar MG. Blood flow in the uterine loop artery and loop vein is bidirectional in the mouse: implications for transport of steroids between fetuses. Physiology & behavior. 1992;52[1]:163–71. pmid:1529001
- 52. Avni R, Raz T, Biton IE, Kalchenko V, Garbow JR, and Neeman M. Unique in utero identification of fetuses in multifetal mouse pregnancies by placental bidirectional arterial spin labeling MRI. Magnetic resonance in medicine. 2012;68[2]:560–70. pmid:22162003
- 53. Raz T, Avni R, Addadi Y, Cohen Y, Jaffa AJ, Hemmings B, et al. The hemodynamic basis for positional- and inter-fetal dependent effects in dual arterial supply of mouse pregnancies. PloS one. 2012;7[12]:e52273. pmid:23284965
- 54. Wahsner J., et al., Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers. Chem Rev, 2019. 119[2]: p. 957–1057. pmid:30350585
- 55. Haaf P., Garg P., Messroghli D.R. et al. Cardiac T1 Mapping and Extracellular Volume [ECV] in clinical practice: a comprehensive review. J Cardiovasc Magn Reson 18, 89 [2017]. https://doi.org/10.1186/s12968-016-0308-4.
- 56. Garg P, Saunders LC, Swift AJ, Wild JM, Plein S. Role of cardiac T1 mapping and extracellular volume in the assessment of myocardial infarction. Anatol J Cardiol. 2018 Jun;19[6]:404–411. Epub 2018 Apr 10. pmid:29638222; PMCID: PMC5998858.
- 57. Schelbert E.B., Testa S.M., Meier C.G. et al. Myocardial extravascular extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans: slow infusion versus bolus. J Cardiovasc Magn Reson 13, 16 [2011]. https://doi.org/10.1186/1532-429X-13-16. pmid:21375743
- 58. Heule R, Ganter C, Bieri O. Variable flip angle T1 mapping in the human brain with reduced T2 sensitivity using fast radiofrequency-spoiled gradient echo imaging. Magn Reson Med. 2016 Apr;75[4]:1413–22. Epub 2015 May 15. pmid:25980525.
- 59.
Fick, Adolf [9 July 1870]. "Ueber die Messung dea Blutquantums in den Herzventrikela". Verhandlungen der Physikalisch-medizinische Gesellschaft zu Würzburg [in German]. 2: XVI–XVII. hdl:2027/mdp.39015076673493. Retrieved 24 Oct 2017. NB: summary of his principle is under point [4] of the proceedings.
- 60.
Rossi Richard J. [2018]. Mathematical Statistics: An Introduction to Likelihood Based Inference. New York: John Wiley & Sons. p. 227. ISBN 978-1-118-77104-4.
- 61. Koenderink J. J. [1986]. Optic flow. Vision Research, 26[1], 161–179. https://doi.org/10.1016/0042-6989[86]90078-7. pmid:3716209
- 62. Horn B. K. P., & Schunck B. G. [1981]. Determining optical flow. Artificial Intelligence, 17[1], 185–203. https://doi.org/10.1016/0004-3702[81]90024-2.
- 63. Welch P., "The use of fast Fourier transform for the estimation of power spectra: A method based on time averaging over short, modified periodograms," in IEEE Transactions on Audio and Electroacoustics, vol. 15, no. 2, pp. 70–73, June 1967,